Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
Tigermed Completes Acquisition of Marti Farm
Tigermed, a leading global provider of clinical research solutions across the full lifecycle of global […]
Machine Solutions Acquires Vela Technologies
Machine Solutions, a provider of advanced equipment and services for the medical device market, has […]
Strata Oncology Announces Addition of Gilead as Strata PATH Trial Collaborator
Strata Oncology, a next-generation precision oncology company enabling smarter and earlier cancer treatment, has today […]
NeuroBo Pharmaceuticals Appoints Joseph Hooker as Interim Chief Executive Officer and President
NeuroBo Pharmaceuticals, a clinical-stage biotechnology company focused on therapies for cardiometabolic diseases, today announced that it […]
Cryoport Announces New Strategic Partnership with Syneos Health to Advance Cell & Gene Therapies
Cryoport, a leading global provider of innovative temperature-controlled supply chain solutions to the life sciences […]
CureLab Veterinary Launches Equity Crowdfunding Campaign on Netcapital to Revolutionize Medicine for Dogs, Cats, and Horses
CureLab Veterinary, an emerging animal health biotech company, has launched its crowdfunding campaign via Netcapital, […]
Asieris Appoints Dr. Linda Wu as Chief Development Officer
Asieris Pharmaceuticals, a global biopharma company specializing in discovering, developing and commercializing innovative drugs for […]
Longevity Biotech Gero Entered a Research Collaboration With Pfizer to Discover Potential Targets for Fibrotic Diseases
Gero today announced that it has entered into a research collaboration with Pfizer to apply Gero’s machine-learning […]
OstomyCure Announces Completion of Patient Recruitment Milestone in Pivotal TIES Clinical Trial
OstomyCure, a clinical-stage medtech company developing revolutionary technologies to transform the lives of people with […]
IASO Bio Raises Nearly $75 Million in Series C1 Funding
IASO Biotherapeutics (IASO Bio), a clinical-stage biopharmaceutical company engaged in discovering, developing, and manufacturing innovative […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more